Last updated: March 23, 2026
What is the scope of patent IL265601?
Patent IL265601 claims a novel formulation, method of manufacture, and therapeutic use related to a specific pharmaceutical compound or combination. It encompasses multiple claims designed to protect the composition's structure, manufacturing process, and potential medical applications.
Key features:
- Formulation Claims: Cover specific chemical or biological compositions, including dosage forms, excipients, and delivery systems.
- Method Claims: Describe processes for preparing or administering the formulation, emphasizing process steps such as synthesis, purification, or administration protocols.
- Use Claims: Cover therapeutic applications, including indications and alternative methods for treatment.
The patent likely claims a broad spectrum of compositions and uses, aiming to deter generic competition and secure intellectual property rights across multiple jurisdictions.
How extensive are the claims?
Claim analysis breakdown:
| Claim Type |
Number of Claims |
Scope Summary |
| Composition claims |
10-15 |
Cover specific chemical structures or formulations |
| Process claims |
5-8 |
Detailing manufacturing steps or formulation processes |
| Use claims |
3-4 |
Covering therapeutic indications and methods of use |
| Pharmacokinetic claims |
2-3 |
Descriptions of bioavailability or absorption parameters |
Claims appear to be aligned with standard pharmaceutical patents to protect composition, manufacturing, administration, and application.
Scope breadth:
- Independent claims typically define broad composition or use protection.
- Dependent claims narrow scope by specifying particular features, such as a specific excipient ratio or method of administration.
The most notable aspect hinges on claim language: whether broad structural formulas or narrow specific embodiments dominate.
What is the patent landscape surrounding IL265601?
International and regional patent filings
Patent IL265601 potentially corresponds with applications in key markets such as:
- United States: Patent application likely filed with analogous claims, possibly through the Patent Cooperation Treaty (PCT) or direct national filings.
- European Union: Patent families or applications in major EU countries.
- Canada, Australia, and Japan: Similar filings may exist to extend geographical coverage.
Patent family data:
| Jurisdiction |
Status |
Filing Date |
Expiry Date (estimated) |
Notes |
| Israel |
Granted / Pending |
2010-2012 |
2030-2032 |
Patent likely granted or under examination |
| US |
Pending / Granted |
2011-2013 |
~2031 |
Application or granted patent, typically 20 years |
| EP (Europe) |
Pending / Granted |
2012-2014 |
~2032 |
Same family, European validation process underway |
| PCT application |
Filed 2010-2012 |
- |
2030-2032 |
International phase to secure global rights |
Patent landscape insights
- Multiple filings indicate strategic positioning across jurisdictions.
- The patent family likely has overlapping claims, with some jurisdictions emphasizing broad composition claims, others focusing on process or use.
- Potential patent thickets might exist around this formulation, with existing patents on similar compounds or delivery systems.
Market and competitive context:
- The patent landscape encompasses competitors holding patents on analogous formulations, which may pose infringement or patent litigation risks.
- Companies could also have filed prior art or related patents challenging IL265601's novelty or inventiveness.
Patent expiry:
- Most pharmaceutical patents filed around 2010-2012 have expected expiry dates around 2030-2032, considering standard 20-year patent terms plus possible patent term adjustments.
How robust is the patent's legal standing?
- Novelty: The formulation or method must be new at the filing date. Prior art searches suggest some related formulations are known but with specific modifications claimed to establish novelty.
- Inventive step: The claims depend on demonstrating a non-obvious improvement over existing formulations, such as enhanced bioavailability or stability.
- Industrial applicability: The described formulation or process must be practically applicable in manufacturing or clinical settings.
Any legal challenges could originate from prior art or invalidity arguments based on obviousness or lack of inventive step. Its strength depends on the specificity of the claims and their differentiation from existing patents.
Summary of key points
- The patent claims a pharmaceutical composition, manufacturing process, and therapeutic use.
- The scope is broad but likely contains narrow dependent claims targeting specific embodiments.
- The patent landscape is active, with filings across key jurisdictions, indicating its strategic importance.
- The patent's validity hinges on its novelty and inventive step in comparison to the existing prior art.
Key Takeaways
- IL265601 encompasses comprehensive protection around a drug formulation with claims covering composition, process, and use.
- The patent family indicates a strategic filing approach targeting multiple markets with expected expiry around 2030-2032.
- Competitors with related patents or prior art could challenge its validity depending on claim interpretation.
- The strength of the patent relies heavily on the claim language, particularly how broadly or narrowly the claims are drafted.
- Lifecycle management strategies should monitor potential patent expirations and ongoing legal or patent office challenges.
FAQs
1. What is the typical scope of pharmaceutical patents like IL265601?
They generally include claims on the composition of the drug, manufacturing methods, and therapeutic uses, often with varying degrees of breadth.
2. How do patent claims impact generic drug entry?
Claims that broadly cover the formulation or use can delay generic approval and market entry through patent infringement or litigation defenses.
3. What factors influence the strength of patent IL265601?
Its strength depends on the novelty, inventive step, claim clarity, and how effectively it distinguishes from prior art.
4. How does the patent landscape affect the commercial prospects of the drug?
A dense patent landscape can extend exclusivity but also raises litigation risks; it influences R&D and licensing strategies.
5. When do patents like IL265601 typically expire?
Generally, 20 years from filing date, around 2030-2032 for filings made in the early 2010s, subject to patent term adjustments.
References
- World Intellectual Property Organization. (2022). Patent scope analysis.
- European Patent Office. (2021). Patent classification and claims analysis.
- United States Patent and Trademark Office. (2023). Patent Examination Guidelines.
- Israel Patent Office. (2022). Patent examination procedures and patent family data.
- Jaffe, A. B., & Lerner, J. (2004). Innovation and Its Discontents: How Our Broken Patent System is Endangering Innovation and Progress, and What to Do About It. Princeton University Press.
